Transmedics Group Inc (TMDX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt TMDX? Forum Prognose

Finanzdaten der Transmedics Group Inc-Aktie (TMDX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	11.78% 160.76	143.82	157.37	143.54	108.76
Cost Of Revenue	13.67% 67.35	59.25	60.78	55.31	47.92
Gross Profit	10.45% 93.41	84.58	96.59	88.23	60.84
Operating Expenses	17.73% 72.14	61.27	60.02	60.78	56.92
Benefits Costs and Expenses	15.18% 139.13	120.79	121.19	116.86	104.52
Costs And Expenses	15.18% 139.13	120.79	121.19	116.86	104.52
Operating Income/Loss	8.70% 21.27	23.30	36.57	27.44	3.923
Nonoperating Income/Loss	233.83% 0.36	-0.269	-0.385	-0.767	0.322
Income/Loss From Continuing Operations Before Tax	6.07% 21.63	23.03	36.18	26.68	4.245
Income Tax Expense/Benefit	6,402% -83.75	-1.288	1.275	0.994	0.029
Income/Loss From Continuing Operations After Tax	333.34% 105.38	24.32	34.91	25.68	4.216
Net Income/Loss	333.34% 105.38	24.32	34.91	25.68	4.216
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.78% 0.0765	34.11	33.91	33.72	33.44
Diluted Average Shares	99.68% 0.1305	40.75	40.56	39.91	35.68
Basic Earnings Per Share	336.62% 3.10	0.71	1.03	0.76	0.13
Diluted Earnings Per Share	292.42% 2.59	0.66	0.92	0.70	0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ZBH

$93.20

0.66%

STE

$214.57

1.05%

DXCM

$64.24

1.56%

PHG

$27.79

1.66%

GEHC

$70.77

0.63%

$81.81

3.31%